These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31810280)

  • 1. Targeting Human Thrombus by Liposomes Modified with Anti-Fibrin Protein Binders.
    Petroková H; Mašek J; Kuchař M; Vítečková Wünschová A; Štikarová J; Bartheldyová E; Kulich P; Hubatka F; Kotouček J; Knotigová PT; Vohlídalová E; Héžová R; Mašková E; Macaulay S; Dyr JE; Raška M; Mikulík R; Malý P; Turánek J
    Pharmaceutics; 2019 Dec; 11(12):. PubMed ID: 31810280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABD-Derived Protein Blockers of Human IL-17 Receptor A as Non-IgG Alternatives for Modulation of IL-17-Dependent Pro-Inflammatory Axis.
    Hlavničková M; Kuchař M; Osička R; Vaňková L; Petroková H; Malý M; Černý J; Arenberger P; Malý P
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human interleukin-23 receptor antagonists derived from an albumin-binding domain scaffold inhibit IL-23-dependent ex vivo expansion of IL-17-producing T-cells.
    Kuchař M; Vaňková L; Petroková H; Cerný J; Osička R; Pelák O; Sípová H; Schneider B; Homola J; Sebo P; Kalina T; Malý P
    Proteins; 2014 Jun; 82(6):975-89. PubMed ID: 24549990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous Bβ-chain C-terminal 12 amino acid elongation variant, BβX462W (Kyoto VI), showed dysfibrinogenemia.
    Okumura N; Terasawa F; Takezawa Y; Hirota-Kawadobora M; Inaba T; Fujita N; Saito M; Sugano M; Honda T
    Blood Coagul Fibrinolysis; 2012 Jan; 23(1):87-90. PubMed ID: 22001526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p19-targeted ABD-derived protein variants inhibit IL-23 binding and exert suppressive control over IL-23-stimulated expansion of primary human IL-17+ T-cells.
    Křížová L; Kuchař M; Petroková H; Osička R; Hlavničková M; Pelák O; Černý J; Kalina T; Malý P
    Autoimmunity; 2017 Mar; 50(2):102-113. PubMed ID: 28100093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro targeting of acoustically reflective immunoliposomes to fibrin under various flow conditions.
    Demos SM; Dagar S; Klegerman M; Nagaraj A; McPherson DD; Onyuksel H
    J Drug Target; 1998; 5(6):507-18. PubMed ID: 9783681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel high-affinity binders of human interferon gamma derived from albumin-binding domain of protein G.
    Ahmad JN; Li J; Biedermannová L; Kuchař M; Sípová H; Semerádtová A; Cerný J; Petroková H; Mikulecký P; Polínek J; Staněk O; Vondrášek J; Homola J; Malý J; Osička R; Sebo P; Malý P
    Proteins; 2012 Mar; 80(3):774-89. PubMed ID: 22113774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent.
    Botnar RM; Buecker A; Wiethoff AJ; Parsons EC; Katoh M; Katsimaglis G; Weisskoff RM; Lauffer RB; Graham PB; Gunther RW; Manning WJ; Spuentrup E
    Circulation; 2004 Sep; 110(11):1463-6. PubMed ID: 15238457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen, fibrin and crosslinking in aging arterial thrombi.
    McBane RD; Ford MA; Karnicki K; Stewart M; Owen WG
    Thromb Haemost; 2000 Jul; 84(1):83-7. PubMed ID: 10928475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of metallochelating microbubbles and study on their site-specific interaction with rGFP-HisTag as a model protein.
    Lukáč R; Kauerová Z; Mašek J; Bartheldyová E; Kulich P; Koudelka Š; Korvasová Z; Plocková J; Papoušek F; Kolář F; Schmidt R; Turánek J
    Langmuir; 2011 Apr; 27(8):4829-37. PubMed ID: 21417344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deposition of fibrinogen on the surface of in vitro thrombi prevents platelet adhesion.
    Owaynat H; Yermolenko IS; Turaga R; Lishko VK; Sheller MR; Ugarova TP
    Thromb Res; 2015 Dec; 136(6):1231-9. PubMed ID: 26482763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen and fibrin structure and functions.
    Mosesson MW
    J Thromb Haemost; 2005 Aug; 3(8):1894-904. PubMed ID: 16102057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of 111In-labeled EPep and FibPep as tracers for fibrin SPECT imaging.
    Starmans LW; van Duijnhoven SM; Rossin R; Berben M; Aime S; Daemen MJ; Nicolay K; Grüll H
    Mol Pharm; 2013 Nov; 10(11):4309-21. PubMed ID: 24099178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterization of a novel single-chain antibody fragment specific against human fibrin clots from phage display antibody library.
    Yan JP; Ko JH; Qi YP
    Thromb Res; 2004; 114(3):205-11. PubMed ID: 15342217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Recombinant Lactococcus lactis Displaying Albumin-Binding Domain Variants against Shiga Toxin 1 B Subunit.
    Zadravec P; Marečková L; Petroková H; Hodnik V; Perišić Nanut M; Anderluh G; Štrukelj B; Malý P; Berlec A
    PLoS One; 2016; 11(9):e0162625. PubMed ID: 27606705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodinated soluble canine fibrin. Preparation and evaluation as a thrombus localizing agent in the dog.
    Coleman RE; Harwig SS; Harwig JF; Sherman LA; Welch MJ
    Circ Res; 1975 Jul; 37(1):35-40. PubMed ID: 1149186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant fibrinogen, gamma275Arg-->Cys, exhibits formation of disulfide bond with cysteine and severely impaired D:D interactions.
    Ishikawa S; Hirota-Kawadobora M; Tozuka M; Ishii K; Terasawa F; Okumura N
    J Thromb Haemost; 2004 Mar; 2(3):468-75. PubMed ID: 15009465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus.
    Overoye-Chan K; Koerner S; Looby RJ; Kolodziej AF; Zech SG; Deng Q; Chasse JM; McMurry TJ; Caravan P
    J Am Chem Soc; 2008 May; 130(18):6025-39. PubMed ID: 18393503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab.
    Dangas G; Badimon JJ; Coller BS; Fallon JT; Sharma SK; Hayes RM; Meraj P; Ambrose JA; Marmur JD
    Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1342-9. PubMed ID: 9714143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
    Eisenberg PR; Jaffe AS; Stump DC; Collen D; Bovill EG
    Circulation; 1990 Oct; 82(4):1159-68. PubMed ID: 2119264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.